Chemoinformaics analysis of 4,5-Di-O-caffeoylquinic acid
| Molecular Weight | 516.455 | nRot | 7 |
| Heavy Atom Molecular Weight | 492.263 | nRig | 1 |
| Exact Molecular Weight | 516.127 | nRing | 3 |
| Solubility: LogS | -2.668 | nHRing | 0 |
| Solubility: LogP | 3.059 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 67.377 |
| nHD | 7 | BPOL | 30.153 |
| QED | 0.586 |
| Synth | 1.996 |
| Natural Product Likeliness | 0.39 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.163 |
| MDCK | 0.0000319 |
| BBB | 0.933 |
| PPB | 0.564391 |
| VDSS | 1.064 |
| FU | 0.488682 |
| CYP1A2-inh | 0.89 |
| CYP1A2-sub | 0.277 |
| CYP2c19-inh | 0.367 |
| CYP2c19-sub | 0.884 |
| CYP2c9-inh | 0.344 |
| CYP2c9-sub | 0.601 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.189 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.295 |
| CL | 9.382 |
| T12 | 0.595 |
| hERG | 0.022 |
| Ames | 0.009 |
| ROA | 0.029 |
| SkinSen | 0.248 |
| Carcinogencity | 0.161 |
| EI | 0.981 |
| Respiratory | 0.181 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.784746 |